Agbo CP - Search Results

1

Microemulsion-based approach for oral delivery of insulin: formulation design and characterization.

Momoh MA, Franklin KC, Agbo CP, Ugwu CE, Adedokun MO, Anthony OC, Chidozie OE, Okorie AN. Momoh MA, et al. Among authors: agbo cp. Heliyon. 2020 Mar 30;6(3):e03650. doi: 10.1016/j.heliyon.2020.e03650. eCollection 2020 Mar. Heliyon. 2020. PMID: 32258491 Free PMC article.

2

Development of lipid-based microsuspensions for improved ophthalmic delivery of gentamicin sulphate.

Onugwu AL, Agbo CP, Nwagwu CS, Uzondu SE, Echezona AC, Nwabueze Ogbonna JD, Kenechukwu FC, Umeyor CE, Uronnachi EM, Akpa PA, Momoh MA, Nnamani PO, Müller-Goymann CC, Attama AA. Onugwu AL, et al. Among authors: agbo cp. Ther Deliv. 2021 Sep;12(9):671-683. doi: 10.4155/tde-2021-0039. Epub 2021 Aug 10. Ther Deliv. 2021. PMID: 34374581

3

Recent and advanced nano-technological strategies for COVID-19 vaccine development.

Nwagwu CS, Ugwu CN, Ogbonna JDN, Onugwu AL, Agbo CP, Echezona AC, Ezeibe EN, Uzondu S, Kenechukwu FC, Akpa PA, Momoh MA, Nnamani PO, Tarirai C, Ofokansi KC, Attama AA. Nwagwu CS, et al. Among authors: agbo cp. Methods Microbiol. 2022;50:151-188. doi: 10.1016/bs.mim.2022.03.001. Epub 2022 Apr 18. Methods Microbiol. 2022. PMID: 38620863 Free PMC article.

4

Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles.

Agbo C, Umeyor C, Kenechukwu F, Ogbonna J, Chime S, Lovelyn C, Agubata O, Ofokansi K, Attama A. Agbo C, et al. Drug Dev Ind Pharm. 2016 Oct;42(10):1708-21. doi: 10.3109/03639045.2016.1171331. Epub 2016 Apr 19. Drug Dev Ind Pharm. 2016. PMID: 27095388

5

Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria.

Agbo CP, Ugwuanyi TC, Ugwuoke WI, McConville C, Attama AA, Ofokansi KC. Agbo CP, et al. J Control Release. 2021 Jun 10;334:224-236. doi: 10.1016/j.jconrel.2021.04.020. Epub 2021 Apr 22. J Control Release. 2021. PMID: 33894303

6

Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.

Onugwu AL, Nwagwu CS, Onugwu OS, Echezona AC, Agbo CP, Ihim SA, Emeh P, Nnamani PO, Attama AA, Khutoryanskiy VV. Onugwu AL, et al. Among authors: agbo cp. J Control Release. 2023 Feb;354:465-488. doi: 10.1016/j.jconrel.2023.01.018. Epub 2023 Jan 19. J Control Release. 2023. PMID: 36642250 Free article. Review.

7

Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.

Onugwu AL, Ugorji OL, Ufondu CA, Ihim SA, Echezona AC, Nwagwu CS, Onugwu SO, Uzondu SW, Agbo CP, Ogbonna JD, Attama AA. Onugwu AL, et al. Among authors: agbo cp. Nanoscale Adv. 2023 Aug 15;5(18):4628-4648. doi: 10.1039/d3na00462g. eCollection 2023 Sep 12. Nanoscale Adv. 2023. PMID: 37705787 Free PMC article. Review.

8

Development, in vitro and in vivo evaluations of novel lipid drug delivery system of Newbouldia laevis (P. Beauv.).

Umeyor C, Anaka E, Kenechukwu F, Agbo C, Attama A. Umeyor C, et al. Nanobiomedicine (Rij). 2016 Nov 22;3:1849543516673445. doi: 10.1177/1849543516673445. eCollection 2016 Jan-Dec. Nanobiomedicine (Rij). 2016. PMID: 29942388 Free PMC article.

9

Alzheimer's Disease: Pathogenesis and Therapeutic Interventions.

Ogbodo JO, Agbo CP, Njoku UO, Ogugofor MO, Egba SI, Ihim SA, Echezona AC, Brendan KC, Upaganlawar AB, Upasani CD. Ogbodo JO, et al. Among authors: agbo cp. Curr Aging Sci. 2022;15(1):2-25. doi: 10.2174/1874609814666210302085232. Curr Aging Sci. 2022. PMID: 33653258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page